Sleep and endocrinology.
A bidirectional interaction between sleep electroencephalogram and endocrine activity is well established in various species including humans. Various hormones (peptides and steroids) participate in sleep regulation. A key role was shown for the reciprocal interaction between sleep-promoting growth hormone-releasing hormone (GHRH) and sleep-impairing corticotropin-releasing hormone (CRH). Changes in the GHRH : CRH ratio result in changes of sleep-endocrine activity. It is thought that the change of this ratio in favour of CRH contributes to aberrations of sleep during ageing and depression (shallow sleep, blunted GH and elevated cortisol). Besides GHRH, ghrelin and galanin enhance slow wave sleep. Somatostatin is another sleep-impairing factor. Neuropeptide Y acts as a CRH antagonist and induces sleep onset. There are hints that CRH promotes rapid eye movement sleep (REMS). In animals prolactin enhances REMS. In humans vasoactive intestinal polypeptide (VIP) appears to play a role in the temporal organization of sleep as, after VIP, the non-REMS-REMS cycle decelerated. Cortisol appears to enhance REMS. Finally, gonadal hormones participate in sleep regulation. Oestrogen replacement therapy and CRH-1 receptor antagonism in depression are beneficial clinical applications of sleep-endocrine research.
Steiger
A
A
Department of Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany. steiger@mpipsykl.mpg.de
D000375:Aging / Q000502:physiology; D003866:Depressive Disorder / Q000503:physiopathology; D004703:Endocrine System / Q000502:physiology*; D006801:Humans; D010455:Peptides / Q000502:physiology; D012890:Sleep / Q000502:physiology*; D013256:Steroids / Q000502:physiology
D010455:Peptides; D013256:Steroids